source
- Compass Pathways reports six-month durability of response in pivotal psilocybin depression trialCompass Pathways announced that patients in the second of its two pivotal psilocybin trials for depression continued to show a therapeutic response for at least six months. The durability data sugg…
- Fresenius Kabi urges removal of dropped Ivenix infusion pumps after safety correctionFresenius Kabi has issued a safety notice for its Ivenix large-volume infusion pumps. The FDA classified the issue as a Class I recall, the most serious level, because the touchscreen can become un…